FLUMIST Research Report 2023: The Most Widely Available Quadrivalent Live Attenuated Influenza Vaccine - Drug Insights and Market Forecasts 2019-2032

Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "FLUMIST QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about FLUMIST QUADRIVALENT for seasonal influenza in the six major markets. A detailed picture of the FLUMIST QUADRIVALENT for seasonal influenza in the 6MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom for the study period 2019 -2032 is provide

Related Keywords

Dublin ,Ireland ,France ,Spain ,United States ,Italy ,United Kingdom ,Germany , ,Clinical Development ,Market Forecast ,Topics Covered ,Marketed Therapies ,Late Stage Emerging Therapies ,Flumist Quadrivalent ,Seasonal Influenza ,